Saturn V Capital Management Lp Top Holdings and 13F Report (2026) About Saturn V Capital Management LpInvestment ActivitySaturn V Capital Management Lp has $697.47 million in total holdings as of June 30, 2026.Saturn V Capital Management Lp owns shares of 23 different stocks, but just 11 companies or ETFs make up 80% of its holdings.Approximately 13.70% of the portfolio was purchased this quarter.About 7.26% of the portfolio was sold this quarter.This quarter, Saturn V Capital Management Lp has purchased 21 new stocks and bought additional shares in 13 stocks.Saturn V Capital Management Lp sold shares of 6 stocks and completely divested from 1 stock this quarter.Largest Holdings Amylyx Pharmaceuticals $83,048,854ALUMIS INC $82,040,566ABIVAX SA $69,143,950Vaxcyte $49,579,891Immix Biopharma $48,028,403 Largest New Holdings this Quarter 89532M101 - Trevi Therapeutics $19,620,602 Holding786700104 - SAGIMET BIOSCIENCES INC $11,439,766 Holding92764N102 - Vir Biotechnology $7,852,852 Holding Largest Purchases this Quarter Trevi Therapeutics 1,052,043 shares (about $19.62M)SAGIMET BIOSCIENCES INC 1,479,918 shares (about $11.44M)Immix Biopharma 964,844 shares (about $9.95M)Celcuity 88,414 shares (about $9.25M)Zura Bio 1,361,159 shares (about $8.03M) Largest Sales this Quarter Ovid Therapeutics 3,503,606 shares (about $9.42M)ALUMIS INC 286,632 shares (about $8.07M)ABIVAX SA 23,831 shares (about $3.18M)MONOPAR THERAPEUTICS INC 33,650 shares (about $3.12M)Invivyd 2,556,796 shares (about $2.23M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSaturn V Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAMLXAmylyx Pharmaceuticals$83,048,854$4,924,919 â–²6.3%4,624,10111.9%HealthcareALUMIS INC$82,040,566$8,065,824 â–¼-9.0%2,915,44311.8%COMABIVAX SA$69,143,950$3,175,719 â–¼-4.4%518,8659.9%SPONSORED ADSPCVXVaxcyte$49,579,891$1,649,846 â–²3.4%852,9147.1%HealthcareIMMXImmix Biopharma$48,028,403$9,947,542 â–²26.1%4,658,4296.9%HealthcarePHVSPharvaris$45,442,339$3,897,858 â–²9.4%1,314,1226.5%HealthcareJAZZJazz Pharmaceuticals$38,781,230$487,482 â–¼-1.2%160,9385.6%HealthcareCELCCelcuity$38,742,669$9,249,873 â–²31.4%370,3185.6%HealthcareIRONDisc Medicine$38,378,752$5,471,165 â–²16.6%524,7305.5%HealthcareCADLCandel Therapeutics$34,027,966$4,193,109 â–²14.1%3,303,6864.9%HealthcareX4 PHARMACEUTICALS INC$32,565,512$2,412,975 â–²8.0%6,973,3434.7%COM NEWMONOPAR THERAPEUTICS INC$28,885,858$3,115,654 â–¼-9.7%311,9764.1%COM NEWDYNE THERAPEUTICS INC$23,486,920$2,018,534 â–²9.4%1,057,4933.4%COMTRVITrevi Therapeutics$19,620,602$19,620,602 â–²New Holding1,052,0432.8%HealthcareZURAZura Bio$12,396,602$8,030,838 â–²184.0%2,101,1191.8%HealthcareSAGIMET BIOSCIENCES INC$11,439,766$11,439,766 â–²New Holding1,479,9181.6%COM SER AOCSOculis$9,499,286$2,331,811 â–²32.5%684,8801.4%HealthcareINHIBIKASE THERAPEUTICS INC$7,854,184$11,390 â–²0.1%3,869,0561.1%COM NEWVIRVir Biotechnology$7,852,852$7,852,852 â–²New Holding770,6431.1%HealthcareIVVDInvivyd$7,321,432$2,230,549 â–¼-23.4%8,392,2881.0%HealthcareALTO NEUROSCIENCE INC$4,824,857$2,476,174 â–²105.4%182,8290.7%COM SHSSATELLOS BIOSCIENCE INC$2,721,2500.0%350,0000.4%COMOVIDOvid Therapeutics$1,783,631$9,424,698 â–¼-84.1%663,0600.3%HealthcareCOGTCogent Biosciences$0$24,119,181 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
